Ignite Creation Date:
2025-12-24 @ 4:37 PM
Ignite Modification Date:
2026-01-24 @ 5:12 AM
Study NCT ID:
NCT05888766
Status:
UNKNOWN
Last Update Posted:
2023-06-05
First Post:
2023-05-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Predict the Response to Acute Treatment of Migraine With Rimegepant 75 mg
Sponsor:
University of Roma La Sapienza
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
S-LT-000002620231
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None